Journal
/
/
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
JoVE Journal
Chemistry
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Chemistry
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
DOI:

09:44 min

January 29, 2019

, ,

Chapters

  • 00:04Title
  • 00:41The Preparation of huA33-TCO
  • 03:54177Lu Radiolabeling of Tz-PEG7-DOTA
  • 05:10In vivo Studies
  • 07:08Results: Longitudinal Therapy Study of Mice Bearing Subcutaneous SW1222 Tumors
  • 09:00Conclusion

Summary

Automatic Translation

This protocol describes the synthesis and characterization of a trans-cyclooctene (TCO)-modified antibody and a 177Lu-labeled tetrazine (Tz) radioligand for pretargeted radioimmunotherapy (PRIT). In addition, it details the use of these two constructs for in vivo biodistribution and longitudinal therapy studies in a murine model of colorectal cancer.

Related Videos

Read Article